Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06160128 · ClinicalTrials.gov registry record
Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)
A clinical trial of Influenza and RSV, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- 400,000
- Enrollment target
- 1
- Study location
NCT06160128 is a study of Influenza and RSV that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 400,000 participants, above the 34,240-participant average among 156 other Influenza trials with a reported enrollment target (1068% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06160128, a study of Influenza and RSV, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- 400,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to comprehensively describe the temporal and geographic utilization of COVID-19 therapies used for mild to moderate disease during different periods of SARS-CoV-2 variant circulation as well as to compare demographic and clinical characteristics of Veterans who are treated or do not receive these different therapies. The investigators will also perform similar descriptive epidemiology for other respiratory viruses, including RSV and influenza and other infectious diseases. This first phase will critically inform feasibility and direction of the second phase, in which the investigators will use target trial emulation design to study the comparative effectiveness of therapies and vaccines for COVID-19, respiratory viruses, including RSV, and influenza, and other infectious diseases.
Conditions Studied
Study Locations (1)
Oregon
- VA Portland Health Care System, Portland, OR - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400,000 participants |
| Start Date | 2022-09-26 |
| Est. Completion | 2027-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06160128
The ClinicalTrials.gov registry entry for NCT06160128 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 400,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 34,240-participant average among 156 other Influenza trials with a reported enrollment target (1068% higher). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Influenza appearing as the primary indexed condition, and to 0 interventions.
NCT06160128 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT06160128 about?
NCT06160128 is a clinical study titled "Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)". The purpose of this study is to comprehensively describe the temporal and geographic utilization of COVID-19 therapies used for mild to moderate disease during different periods of SARS-CoV-2 variant circulation as well as to compare demographic and clinical characteristics of Veterans who are treat...
What is the current status of trial NCT06160128?
This trial is currently recruiting. The enrollment target is 400,000 participants. The study started on 2022-09-26. Estimated completion is 2027-09-30.
What conditions does trial NCT06160128 study?
This clinical trial studies the following conditions: Influenza, RSV, COVID-19, SARS-CoV-2 Infection.
Who is sponsoring clinical trial NCT06160128?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06160128 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Influenza
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
pH1N1 Blinded Challenge Study
RECRUITING · Phase 1
-
B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults
RECRUITING · Phase 4
-
High vs. Standard Dose Influenza Vaccines in Lung Transplant (Repeater)
RECRUITING · Phase 2
-
Influenza Immunization in Adults Over Age 75
RECRUITING · NA
-
H5N1 Milk Detection Study
RECRUITING · NA
-
Screening for LID Clinical Studies Unit Healthy Volunteer Protocols
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.